Cargando…

Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)

BACKGROUND: Targeted cancer therapy is often complex, involving multiple agents and chemotherapeutic partners. In Australia, prescribing restrictions are put in place to reflect existing evidence of cost-effectiveness of these medicines. As therapeutic options continue to expand, these restrictions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daniels, Benjamin, Girosi, Federico, Tervonen, Hanna, Kiely, Belinda E., Lord, Sarah J., Houssami, Nehmat, Pearson, Sallie-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061975/ https://www.ncbi.nlm.nih.gov/pubmed/30048453 http://dx.doi.org/10.1371/journal.pone.0198152

Ejemplares similares

Metastatic breast cancer incidence, site and survival in Australia, 2001–2016: a population-based health record linkage study protocol
por: Lord, Sarah J, et al.
Publicado: (2019)

Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort
por: Daniels, Benjamin, et al.
Publicado: (2021)

Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort
por: Daniels, Benjamin, et al.
Publicado: (2017)

Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006–2014)
por: Daniels, Benjamin, et al.
Publicado: (2018)

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)
por: Daniels, Benjamin, et al.
Publicado: (2019)

Long term risk of distant metastasis in women with non‐metastatic breast cancer and survival after metastasis detection: a population‐based linked health records study
por: Lord, Sarah (Sally) J, et al.
Publicado: (2022)

Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)
por: Tang, Monica, et al.
Publicado: (2019)

Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)
por: Tang, Monica, et al.
Publicado: (2020)

Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
por: Daniels, Benjamin, et al.
Publicado: (2017)

Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia
por: Brett, Jonathan, et al.
Publicado: (2018)

Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
por: Daniels, Benjamin, et al.
Publicado: (2020)

Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Identifying incident cancer cases in dispensing claims: A validation study using Australia’s Repatriation Pharmaceutical Benefits Scheme (PBS) data
por: Daniels, B, et al.
Publicado: (2019)

Evaluation of radiographers’ mammography screen-reading accuracy in Australia
por: Debono, Josephine C, et al.
Publicado: (2015)

Persistence and Adherence to Cardiovascular Medicines in Australia
por: de Oliveira Costa, Juliana, et al.
Publicado: (2023)

Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline
por: Marinovich, M. Luke, et al.
Publicado: (2023)

Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
por: Houssami, Nehmat
Publicado: (2017)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Houssami, Nehmat
Publicado: (2021)

De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995
por: Lord, SJ, et al.
Publicado: (2022)

Screening women with a personal history of breast cancer: overview of the evidence on breast imaging surveillance
por: Houssami, Nehmat, et al.
Publicado: (2018)

The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening
por: Houssami, Nehmat, et al.
Publicado: (2017)

Reflections from Women with an Interval Breast Cancer Diagnosis: A Qualitative Analysis of Open Disclosure in the BreastScreen Western Australia Program
por: Claringbold, Lily, et al.
Publicado: (2023)

General practitioners’ (GPs) understanding and views on breast density in Australia: a qualitative interview study
por: Nickel, Brooke, et al.
Publicado: (2021)

Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
por: Tadrous, Mina, et al.
Publicado: (2021)

Staging the axilla in women with breast cancer: the utility of preoperative ultrasound-guided needle biopsy
por: Houssami, Nehmat, et al.
Publicado: (2014)

Towards consensus on managing high mammographic density in population breast screening?
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2023)

A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer
por: Yu, Xue Qin, et al.
Publicado: (2014)

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
por: Tang, Monica, et al.
Publicado: (2021)

Human Metapneumovirus, Australia, 2001–2004
por: Sloots, Theo P., et al.
Publicado: (2006)

Changes in antibiotic prescribing following COVID‐19 restrictions: Lessons for post‐pandemic antibiotic stewardship
por: Gillies, Malcolm B., et al.
Publicado: (2021)

Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia
por: Bruno, Claudia, et al.
Publicado: (2020)

Using data linkage to enhance the reporting of cancer outcomes of Aboriginal and Torres Strait Islander people in NSW, Australia
por: Tervonen, Hanna E., et al.
Publicado: (2019)

The changing epidemiology of shigellosis in Australia, 2001–2019
por: Ibrahim, Aaliya F., et al.
Publicado: (2023)

Did Australia's COVID-19 Restrictions Impact Statin Incidence, Prevalence or Adherence?
por: Livori, Adam C., et al.
Publicado: (2023)

Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation
por: Staub, Lukas P, et al.
Publicado: (2012)

Antidepressant prescribing patterns in Australia
por: Malhi, Gin S., et al.
Publicado: (2022)

Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women
por: Lawson, James S, et al.
Publicado: (2001)

Artificial intelligence (AI) in breast cancer care - Leveraging multidisciplinary skills to improve care()
por: Cardoso, Maria Joao, et al.
Publicado: (2020)

The geographic distribution of private health insurance in Australia in 2001
por: Glover, John, et al.
Publicado: (2009)

Review of the Health, Welfare and Care Workforce in Tasmania, Australia: 2011–2016
por: Jessup, Belinda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uvp36loa76sskdvshue08nh904